|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 37.47 USD | +1.19% |
|
+4.14% | -19.07% |
| 05-15 | Collegium Pharmaceutical, Inc. Announces Appointment of Michael Donovan as Director | CI |
| 05-12 | Collegium completes acquisition of Azstarys® from Corium Therapeutics | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +1.19% | +4.14% | +12.25% | +14.97% | -19.07% | +23.46% | +75.18% | +62.63% | +200.00% | 1.22B | |
| -1.14% | -2.43% | +6.07% | +29.45% | +11.67% | +53.72% | +159.07% | +409.75% | +1,399.70% | 1,070B | |
| -1.41% | +0.32% | +11.41% | +7.62% | +25.31% | +66.23% | +60.48% | +54.39% | +111.46% | 624B | |
| -2.42% | +0.18% | +12.12% | +23.26% | +11.50% | +34.59% | +85.62% | +120.13% | +302.02% | 450B | |
| -1.70% | +0.53% | +4.13% | +7.11% | +3.78% | +31.00% | +25.82% | -3.65% | +35.48% | 328B | |
| +0.44% | +0.54% | +2.75% | -5.23% | +2.80% | +38.74% | +40.22% | +63.73% | +208.61% | 292B | |
| +0.14% | -1.04% | +6.75% | +4.56% | +14.29% | +28.33% | +47.52% | +47.42% | +56.48% | 284B | |
| +1.76% | +3.97% | +20.26% | +39.13% | +0.57% | -25.86% | -39.09% | +20.86% | +78.84% | 217B | |
| -2.06% | +1.63% | +4.82% | +6.97% | +11.96% | +22.87% | +64.34% | +50.40% | +134.82% | 198B | |
| -1.26% | +2.60% | +0.35% | -7.51% | +5.60% | +15.98% | +70.00% | +89.46% | +51.18% | 161B | |
| -2.47% | -2.67% | -8.91% | -14.77% | -4.74% | -6.54% | -33.43% | -39.63% | -33.85% | 135B | |
| +0.29% | +5.99% | +18.52% | +21.94% | +16.81% | +15.22% | +53.17% | +164.73% | +490.66% | 134B | |
| -2.46% | -3.18% | -1.00% | -4.43% | +5.12% | +20.84% | -10.62% | -14.93% | -23.23% | 116B | |
| +0.40% | +0.61% | +4.18% | -4.91% | +9.24% | +42.82% | +51.44% | +10.95% | -3.84% | 106B | |
| +0.75% | -0.01% | -2.09% | -6.76% | -9.25% | -8.94% | -20.10% | -13.51% | +1.39% | 102B | |
| +1.05% | +1.14% | +2.08% | -12.80% | -7.56% | +6.72% | +95.03% | +80.36% | +515.34% | 76.45B | |
| +0.06% | +6.09% | +43.91% | +30.79% | +38.77% | +96.41% | +5.33% | +0.77% | -42.04% | 57.41B | |
| +4.26% | +7.25% | +20.58% | +0.69% | -4.70% | +6.59% | +18.00% | -8.52% | +274.81% | 55.16B | |
| -1.25% | +5.68% | +7.88% | -6.04% | +12.68% | +23.48% | +23.54% | +47.84% | +23.87% | 53.69B | |
| +1.81% | +5.03% | +10.33% | -1.08% | -2.56% | -1.64% | +18.26% | - | - | 42.21B | |
| Average | -0.03% | +2.11% | +8.82% | +6.15% | +6.11% | +24.20% | +39.49% | +60.17% | +199.04% | 225.18B | |
| Weighted average by Cap. | -0.77% | +0.97% | +7.69% | +12.70% | +10.47% | +35.58% | +69.10% | +136.62% | +438.46% |
- Stock Market
- Stocks
- COLL Stock
- Sector Collegium Pharmaceutical, Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
